BEAM
Beam Therapeutics Inc
25.70$
+4.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | 23,043.8 | 57,668.5 | 51,339.9 | 204,714.4 | 200,700.4 | 333,602.4 | 7,394.2 | 104.5 | 65.3 | 35.3 | 36.4 | 45.4 | 28.8 | 30.4 | 23.4 | 6.0 | 7.5 | 5.5 | 5.8 | 32.3 | 27.0 | 28.8 | 44.7 | 20.8 | 15.0 | 22.9 | |
| – | – | – | – | – | – | – | – | 2.1 | 6.0 | 6.2 | 20.0 | 11.4 | 14.6 | 6.8 | 6.6 | 4.7 | 3.4 | 4.7 | 3.8 | 2.9 | 3.0 | 2.4 | 2.3 | 3.0 | 2.3 | 2.6 | 2.8 | 1.5 | 1.7 | 2.6 | 2.3 | 2.1 | 3.4 | |
| – | – | – | – | – | – | – | – | 18,056.7 | 52,714.0 | 45,847.0 | 198,221.3 | 197,097.4 | 325,179.1 | 6,626.3 | 94.0 | 60.6 | 32.1 | 34.8 | 41.8 | 25.7 | 27.7 | 21.4 | 4.8 | 6.7 | 4.7 | 5.2 | 28.1 | 18.9 | 24.3 | 40.2 | 18.8 | 13.9 | 22.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 26.6 | 22.1 | 84.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -15.7% | -6.8% | -8.1% | -2.3% | -2.7% | -1.9% | -2.3% | -2.1% | 3.8% | 4.5% | 1.2% | -1.0% | -16.0% | -15.6% | -20.6% | -8.1% | -6.3% | -8.0% | -7.2% | -17.3% | -21.0% | -20.5% | -14.1% | -12.4% | -15.6% | -10.4% | |
| Margins | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | -279,020.8% | -306,829.2% | -378,837.5% | -429,812.5% | -1,132,133.3% | -1,241,395.8% | -41,226.1% | -347.8% | -78.3% | -77.4% | -81.7% | -411.5% | -350.9% | -360.2% | -370.4% | -15.8% | -17.1% | -16.9% | -16.2% | -478.7% | -500.1% | -557.5% | -442.2% | -43.5% | 38.0% | 100.0% | |
| – | – | – | – | – | – | – | – | -376,670.8% | -412,645.8% | -493,050.0% | -553,166.7% | -1,269,908.3% | -1,406,112.5% | -47,347.0% | -757.0% | -445.2% | -378.7% | -340.4% | -555.6% | -470.9% | -475.8% | -488.4% | -46.7% | -50.3% | -52.3% | -52.2% | -654.3% | -677.5% | -739.9% | -837.1% | -274.6% | -226.6% | -242.3% | |
| – | – | – | – | – | – | – | – | -396,558.3% | -464,712.5% | -529,075.0% | -810,800.0% | -1,523,725.0% | -1,698,870.8% | -51,395.0% | -714.9% | -395.4% | -304.2% | -343.1% | -474.5% | -412.5% | -408.1% | -384.6% | -35.1% | -37.3% | -40.6% | -41.1% | -593.1% | -609.2% | -661.3% | -744.4% | -57.2% | -39.7% | -54.7% | |
| – | – | – | – | – | – | – | – | -361,454.2% | -391,725.0% | -415,145.8% | -467,075.0% | -548,812.5% | -646,758.3% | -17,152.8% | -218.1% | 245.9% | 159.9% | 42.9% | -43.4% | -460.9% | -474.6% | -480.5% | -48.4% | -46.9% | -43.5% | -41.6% | -560.8% | -567.7% | -589.9% | -632.6% | -257.7% | -234.0% | -238.9% | |
| Returns | ||||||||||||||||||||||||||||||||||
| – | – | – | -86.0% | -88.6% | -88.0% | -59.7% | -77.6% | -36.4% | -48.3% | -63.5% | -79.2% | -86.6% | -74.3% | -47.0% | -44.8% | -28.7% | -29.2% | -44.2% | -39.4% | -41.5% | -40.3% | -40.3% | -13.5% | -14.7% | -16.7% | -18.1% | -51.4% | -34.5% | -38.1% | -42.9% | -6.5% | -5.6% | -8.0% | |
| – | – | – | -69.0% | – | -70.0% | -44.4% | -50.2% | -29.5% | -37.2% | -45.6% | -43.1% | -52.8% | -45.7% | -34.7% | -25.1% | -16.4% | -16.5% | -23.4% | -21.5% | -23.7% | -24.2% | -24.3% | -9.1% | -9.9% | -11.3% | -12.3% | -34.1% | -26.4% | -28.7% | -31.6% | -5.4% | -4.4% | -6.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | -36 | -35 | -32 | -120 | -119 | -132 | -156 | -86 | -202 | -600 | -547 | -283 | -252 | -147 | -222 | -239 | -214 | -157 | -423 | -276 | -280 | -217 | -268 | -515 | -269 | -255 | -281 | -173 | -104 | |
| – | – | – | 80.3% | – | 79.6% | 74.3% | 64.7% | 81.0% | 76.9% | 71.9% | 54.4% | 60.9% | 61.4% | 73.8% | 56.1% | 57.0% | 56.4% | 52.9% | 54.7% | 57.2% | 59.9% | 60.4% | 67.2% | 67.2% | 67.7% | 67.6% | 66.5% | 76.6% | 75.2% | 73.7% | 83.6% | 78.6% | 77.0% | |
| – | – | – | – | – | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | |
| Per Share | ||||||||||||||||||||||||||||||||||
| – | – | – | -3.28 | -3.38 | -3.60 | -2.15 | -2.55 | -3.10 | -2.26 | -2.54 | -3.23 | -6.07 | -6.55 | -6.05 | -5.45 | -3.47 | -3.33 | -4.48 | -4.08 | -4.38 | -4.29 | -3.97 | -1.60 | -1.65 | -1.74 | -1.74 | -4.55 | -4.40 | -3.91 | -4.04 | -0.76 | -0.63 | -0.82 | |
| – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.76 | 0.88 | 1.10 | 1.31 | 0.86 | 1.06 | 1.05 | 1.03 | 4.57 | 4.42 | 4.28 | 4.24 | 0.77 | 0.72 | 0.59 | 0.54 | 1.33 | 1.59 | 1.50 | |
| -3.29 | – | – | 3.81 | 3.81 | 4.09 | 3.61 | 3.29 | 8.51 | 4.67 | 3.99 | 4.08 | 7.02 | 8.82 | 12.86 | 12.16 | 12.07 | 11.40 | 10.16 | 10.36 | 10.54 | 10.63 | 9.86 | 11.87 | 11.18 | 10.38 | 9.60 | 8.86 | 12.77 | 10.26 | 9.42 | 11.80 | 11.28 | 10.23 | |
| – | – | – | -0.95 | -1.62 | -2.00 | -2.24 | -2.75 | -2.82 | -1.90 | -1.99 | -1.86 | -2.19 | -2.50 | -2.02 | -1.66 | 2.16 | 1.75 | 0.56 | -0.37 | -4.89 | -4.98 | -4.96 | -2.21 | -2.07 | -1.86 | -1.76 | -4.30 | -4.10 | -3.49 | -3.44 | -3.43 | -3.72 | -3.57 | |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.